Navigation Links
iLeverage Announces the Successful Sale of the BICO Patent Portfolio for Near-Infrared Non-Invasive Blood Analytes Measurement
Date:12/13/2010

SAN FRANCISCO, Dec. 13, 2010 /PRNewswire/ -- iLeverage (www.ilvrge.com), a leading patent broker, today announced the successful closing of the Biocontrol patent portfolio sale.

The patents were offered to companies that participate in the relevant markets as well as to a number of IP licensing companies.  After announcing the auction date on Tuesday Dec. 7, iLeverage received several offers; the most compelling came from the licensing companies.

"We met with leaders of the medical monitoring market in the USA and in Europe with the hope that an operating company would acquire the patents, however due to the wide coverage of this portfolio and its relatedness to so many different companies, the patents were given the highest values by licensing companies – a natural result from an economic standpoint," said Uzi Aloush, iLeverage's CEO. For more information, please see www.ilvrge.com.

RELATED LINKS

www.ilvrge.com/bico


'/>"/>
SOURCE iLeverage
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Stryker Announces Election of New Director
2. Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder
3. HeartWare International, Inc. Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
4. MTEC Announces Release of NexGen Speech Recognition Editing and Medical Transcription Training Program
5. Physiotherapy Associates Announces New Multiple Sclerosis Specialty Treatment Program
6. Anthera Announces Update Call Regarding Vial Problems
7. HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
8. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
9. Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia
10. Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial
11. Stryker Announces Additional $500 Million Share Repurchase Program and Declares a 20% Increase in Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):